Mr. Almeida assumed the roles in January 2016 following more than three decades in the healthcare industry, according to a Baxter news release. Brent Shafer, the company’s former lead independent director, was appointed Baxter’s chair and interim CEO.
The company announced Mr. Almeida’s retirement less than a week after the company fully restored operations at its manufacturing plant in Marion, N.C. In late September, the facility — which was the nation’s largest manufacturer of intravenous and peritoneal dialysis solutions — suffered severe flooding from Hurricane Helene.
The site temporarily closed, and as Baxter worked on recovery efforts, health systems experienced a sudden dearth of IV fluid supply. Some hospitals and systems delayed elective and nonemergency procedures due to the shortage.
Mr. Almeida will serve in an advisory capacity through Oct. 31, according to Baxter. Board member Nancy Schlichting is now lead independent director, and the head of Baxter’s Medical Products & Therapies business segment, Heather Knight, has assumed the COO position.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
